Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citius Pharmaceuticals Inc (CTXR) vs PulteGroup, Inc. (PHM) Price & Performance

Citius Pharmaceuticals IncTrade
PulteGroup, Inc.Trade

Price performance (Past 24H)

Key statistics

Citius Pharmaceuticals Inc vs PulteGroup, Inc. — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while PulteGroup, Inc. trades at $132.77 (market cap $25.22B). The key difference: PulteGroup, Inc. is far larger — about 1260.4× Citius Pharmaceuticals Inc's market cap, and PulteGroup, Inc. pays a 0.79% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

CTXRPHM
Market Cap
$20.01M$25.22B
Sector
HealthConsumer Cyclical
52-Week High
$1.82$142.56
52-Week Low
$0.48$110.11
Enterprise Value
$16.23M$25.64B
Dividend Yield
0.79%

Returns comparison

Trailing returns across standard periods

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR

About PulteGroup, Inc.

PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.

Read more on PHM